Systematic Review And Meta-Analysis Of Psoriasis Treatments.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-06-30

Study Completion Date

2011-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints including the Physician Global Assessment (PGA), Dermatology Life Quality Index (DLQI), and Short-Form 36 (SF-36). A traditional meta-analysis and a mixed treatment comparison was conducted on the extracted data.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis

NCT02969018

Chronic Plaque Psoriasis

COMPLETED PHASE2

Study of SFA002 in Patients with Mild to Moderate Psoriasis Plaques

NCT05642182

Psoriasis

RECRUITING PHASE1

A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

NCT00293917

Psoriasis

COMPLETED PHASE3

Combining Topical Corticosteroid and LCD Treatment for Localized Plaque Psoriasis

NCT00769184

Psoriasis

COMPLETED NA

A Randomized Control Trial of Patient-initiated Hospital Follow-up for Patients With Psoriasis

NCT02382081

Psoriasis

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This project involved a systematic literature review of published trials of treatments for moderate-to-severe plaque psoriasis. Data was extracted from the publications on various psoriasis endpoints including the Physician Global Assessment (PGA), Dermatology Life Quality Index (DLQI), and Short-Form 36 (SF-36). A traditional meta-analysis and a mixed treatment comparison was conducted on the extracted data. We included all published randomized controlled trials of treatments for moderate-to-severe psoriasis that met the study inclusion criteria.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Psoriasis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Psoriasis

Published data on moderate-to-severe plaque psoriasis.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Randomized controlled clinical trials of treatments for moderate-to-severe plaque psoriasis.
* Trials had to evaluate at least one of the following: Physician's Global Assessment (PGA), Dermatology Life Quality Index (DLQI) and/or the Short-Form 36 (SF-36).

Exclusion Criteria

Observational studies

* Trials that did not report the Physician's Global Assessment (PGA),
* Dermatology Life Quality Index (DLQI) or the Short-Form 36 (SF-36).

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No